A Trial Study: The Effect of Low Dose Human Chorionic Gonadotropin on the Symptoms of Benign Prostatic Hyperplasia

Abstract

These findings suggest that HCG may provide a well tolerated and beneficial therapy for BPH that will be investigated in subsequent studies.

Evaluation of a novel immunomodulator composed of human chorionic gonadotropin and bacillus Calmette-Guerin for treatment of canine mast cell tumors in clinically affected dogs

“…As with BCG, hCG has been investigated as an immunomodulator for the treatment of inflammatory and neoplastic diseases in humans. [11][12][13] Human chorionic gonadotropin is a glycoprotein hormone that is produced and secreted by the trophoblastic cells of the uterus during pregnancy. Human chorionic gonadotropin is a member of a superfamily of structurally related growth factors including transforming growth factor, nerve growth factor, and platelet-derived growth factor.…”